Skip to content
Lomefloxacin
Maxaquin (lomefloxacin) is a small molecule pharmaceutical. Lomefloxacin was first approved as Maxaquin on 1992-02-21. It is used to treat bronchitis, escherichia coli infections, klebsiella infections, proteus infections, and pseudomonas infections amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
respiratory tract diseasesD012140
urogenital diseasesD000091642
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Lomefloxacin hydrochloride
Tradename
Company
Number
Date
Products
MAXAQUINPharmacia & UpjohnN-020013 DISCN1992-02-21
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bronchitis—D001991J40
escherichia coli infectionsEFO_1001318D004927B96.20
klebsiella infectionsEFO_1001353D007710—
proteus infectionsEFO_1001130D011512—
pseudomonas infectionsEFO_0001076D011552—
staphylococcal infections—D013203A49.01
streptococcal infectionsEFO_1001476D013290—
urinary tract infectionsEFO_0003103D014552N39.0
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01M: Quinolone antibacterials
— J01MA: Fluoroquinolone antibacterials, systemic
— J01MA07: Lomefloxacin
S: Sensory organ drugs
— S01: Ophthalmologicals
— S01A: Antiinfective ophthalmologics
— S01AE: Fluoroquinolone antiinfectives, ophthalmologic
— S01AE04: Lomefloxacin
HCPCS
No data
Clinical
Clinical Trials
37 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Opioid-related disordersD009293EFO_0005611F11884—119
Marijuana abuseD002189EFO_0007191F12—21——2
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Post-traumatic stress disordersD013313EFO_0001358F43.1—1———1
AnxietyD001007EFO_0005230F41.1—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—3————3
Neonatal abstinence syndromeD009357EFO_0005799P96.12————2
Substance-related disordersD019966EFO_0003890F132————2
Substance withdrawal syndromeD013375EFO_00058001————1
Liver failureD017093HP_0001399K72.91————1
Cocaine-related disordersD019970F141————1
Heroin dependenceD006556EFO_00042401————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLOMEFLOXACIN
INNlomefloxacin
Description
Lomefloxacin is a fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery. It has a role as an antimicrobial agent, a photosensitizing agent and an antitubercular agent. It is a quinolone, a N-arylpiperazine, a quinolinemonocarboxylic acid, a quinolone antibiotic and a fluoroquinolone antibiotic.
Classification
Small molecule
Drug classantibacterials (quinolone derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21
Identifiers
PDB—
CAS-ID98079-51-7
RxCUI28872
ChEMBL IDCHEMBL561
ChEBI ID116278
PubChem CID3948
DrugBankDB00978
UNII IDL6BR2WJD8V (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,391 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
123 adverse events reported
View more details